James pfp
James

@jamesp

The OpenAI of Longevity... Before OpenAI launched ChatGPT, Sam Altman invested all his networth in two companies. One of them, Retro Biosciences, is a longevity company He was their sole investor, putting $180m in. Apparently talks to the CEO every weekend. They aim for therapeutics in patients by end of decade
1 reply
0 recast
2 reactions